Generics 357

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Diclofenac potassium manufacturers

357 products found

Filters

357 products found

diclofenac potassium

Tablets 12.5 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
DCP successful
Manufacturer #422

A pharmaceutical manufacturer based in the EU that has been active in 100+ countries selling its products in Europe, North America, Africa, the Middle East, and Asia for 40+ years. Main therapeutic areas include CNS, cardiovascular medication, and anti-infectives. The company's production lines are EU GMP-compliant. Key production lines are Rx and OTC. The company owns 20+ branches in Europe, Africa, and Asia.

Manufacturer usually replies in 5 days

diclofenac potassium

Tablets, film coated 25 mg, 50 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Comments
Dossier availability date: Q3 2024
Manufacturer #422

A pharmaceutical manufacturer based in the EU that has been active in 100+ countries selling its products in Europe, North America, Africa, the Middle East, and Asia for 40+ years. Main therapeutic areas include CNS, cardiovascular medication, and anti-infectives. The company's production lines are EU GMP-compliant. Key production lines are Rx and OTC. The company owns 20+ branches in Europe, Africa, and Asia.

Manufacturer usually replies in 5 days

diclofenac potassium

Sachets 50 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Manufacturer #13684
A pharmaceutical manufacturer based in the EU that has been active in Europe, CIS, Asia, Africa, and MENA for 20+ years. The main therapeutic areas include dermatology, ophthalmology, and gynecology. The company's production lines are GMP-compliant.

Manufacturer usually replies in 8 days

diclofenac potassium

Sachets 50 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #15070
A pharmaceutical manufacturer based in the EU that is selling its products in EU, CIS, and Asia. Key production lines are Rx, OTC, medical devices, and nutraceuticals. The company's production lines are EU GMP-compliant.

Manufacturer usually replies in 8 days

diclofenac potassium

Tablets 50 mg

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
United States
GMP approvals
FDA
Unavailable markets
United States
Registered in
United States
Comments
Available Only For Non-USA
Manufacturer #28190

Manufacturer usually replies in 8 days

diclofenac potassium + serratiopeptidase

Tablets, film coated 50 mg + 10 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO, India
Registered in
India
Available for
Licensing with supply, Distribution only
MAs for sale
India
Manufacturer #22627

Manufacturer usually replies in 4 days

diclofenac potassium + paracetamol + chlorzoxazone

Tablets 50 mg + 325 mg + 250 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO, India
Registered in
India
Available for
Licensing with supply, Distribution only
MAs for sale
India
Manufacturer #22627

Manufacturer usually replies in 4 days

diclofenac potassium + paracetamol

Tablets 50 mg + 325 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO, India
Registered in
India
Available for
Licensing with supply, Distribution only
MAs for sale
India
Manufacturer #22627

Manufacturer usually replies in 4 days

diclofenac potassium + paracetamol + serratiopeptidase

Tablets 50 mg + 325 mg + 10 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO, India
Registered in
India
Available for
Licensing with supply, Distribution only
MAs for sale
India
Manufacturer #22627

Manufacturer usually replies in 4 days

diclofenac potassium + serratiopeptidase

Tablets 50 mg+10 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
FDA
Manufacturer #18850

Manufacturer usually replies in 2 days

diclofenac potassium + paracetamol + serratiopeptidase

Tablets 50 mg+325 mg+10 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
FDA
Manufacturer #18850

Manufacturer usually replies in 2 days

diclofenac potassium + paracetamol

Tablets 50 mg + 500 mg , 50 mg + 650 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #15176

Manufacturer usually replies in 4 days

diclofenac potassium

Tablets 100 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #15176

Manufacturer usually replies in 4 days

diclofenac potassium + chlorzoxazone + paracetamol

Tablets 50 MG + 250 MG + 500 MG, 50 MG + 250 MG + 325 MG

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, TGA
Manufacturer #18120

Manufacturer usually replies in 7 days

diclofenac potassium + paracetamol

Tablets 50 mg + 325 mg, 50 mg + 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, TGA
Manufacturer #18120

Manufacturer usually replies in 7 days

diclofenac potassium

Capsules 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
EU GMP
Manufacturer #10281
It is part of the pharmaceutical and medicine manufacturing industry and is located in Europe. The company's purpose is to be on the lookout for new ways to improve human health and quality of life. Respect for the individual, openness to progress, reasonable power, and respect for the work, workplace, and community are the company's principles.

Manufacturer usually replies in 5 days

diclofenac potassium

Capsules 12.5 mg, 25 mg

Dossier type
CTD
Dossier status
Under development
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
Iraq
Comments
Reference product : Voltaren Duo Soft Gels - DE
Manufacturer #656
It is a fully integrated developer, manufacturer, and marketer of a wide range of soft gelatin formulations, with a strong regulatory and infrastructure back end to support its research and development and global market expansion strategy. The company began licensing and distributing professionally evaluated components and formulations in the OTC and Nutraceutical categories in 2016.

Manufacturer usually replies in 8 days

diclofenac potassium

Suppositories 12.5 mg, 25 mg, 75 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Egypt
GMP approvals
Egypt
Manufacturer #21899

Manufacturer usually replies in 1 days

diclofenac potassium

Capsules 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Egypt
GMP approvals
Egypt
Manufacturer #21899

Manufacturer usually replies in 1 days

diclofenac potassium

Tablets 25 mg, 12.5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Egypt
GMP approvals
Egypt
Manufacturer #21899

Manufacturer usually replies in 1 days

Want to view all 357 products? Create your free account today!

Diclofenac potassium

Diclofenac potassium is a Nonsteroidal anti-inflammatory drug (NSAID). It treats muscle pain, back pain, dental pain, menstrual cramps, and injuries caused by sports. It gives relief from pain, swelling, and joint stiffness in individuals suffering from arthritis. The main benefit is using this medication is to return to a more normal day of activity by reducing the hurt and stiffness in the body. It is commonly recommended for Rheumatoid arthritis, Osteoarthritis, pain in the lower back, pain in migraine attacks, Acute musculoskeletal disorders, and trauma, especially frozen shoulder, tendinitis, bursitis, tenosynovitis, strains sprains, dislocations. It is also used to get relief from pain in fractures, Ankylosing spondylitis, Acute gout. And finally, it is also used for pain and inflammation management in orthopedic, dental, or other minor surgeries, Pyrophosphate arthropathy, and associated disorders. Diclofenac potassium is sold under the brand names like Cambia, Zipsor among others. Applied Pharma Research APR SA is the current Patent owner which it received in 2012. However, the development of this medicine dates back to 1965, when Gelgy Chemical Corp filed for the first patent for the preparation of Diclofenac potassium.

Dosage and administration

Diclofenac potassium is available as tablets, immediate-release tablets, and an oral solution. The oral solution is taken through the mouth, and the tablets are swallowed with liquid, preferably before meals. they should not be chewed or divided. For pain Adults, are given a daily dose of 100-150mg, given in two or three doses. For milder cases, a daily dose, given in 2 or 3 equal doses totaling 75-100mg every day is sufficient. in the treatment of migraine, patients are given an initial dose of 50mg, to be taken when you start feeling the first signs of an impending attack. If it does not reduce the migraine in 2 hours, you can take an additional dose of 50mg. Diclofenac Potassium Tablets should not give to children under the age of 14 years.

The cost of Diclofenac potassium

In the USA, the consumers pay an average retail price of $55.86 for 30 tablets of 50mg. there is a wide range of tablets, where the cost range between USD1 and USD 14 for 100 tablets from a different variety of brands. Not only this, the cost varies by tablets, immediate-release tablets, and oral solution.

How does Diclofenac potassium work?

Diclofenac Potassium has potassium salt of diclofenac, a non-steroidal compound with analgesic, anti-inflammatory, and anti-pyretic properties. Diclofenac Potassium strongly inhibits prostaglandin biosynthesis and acts as a modulator of arachidonic acid release and uptake. Its tablets work quickly giving relief so are used for the treatment of acute episodes of pain and inflammation. In migraine attacks it actions relieve the headache and improve symptoms of nausea from the headache.

Finding Diclofenac Potassium Manufacturers and Suppliers:

The process of finding trusted Diclofenac Potassium manufacturers and Diclofenac Potassium suppliers can be made quicker and more accessible by using Pipelinepharma's an online platform, a B2B marketplace that lets you finalize the deals of pharmaceutical products in a matter of a few clicks. Also, it is easy to use an online platform to grow your business opportunities. The robust search engine makes it convenient to search for manufacturers and suppliers of Diclofenac Potassium. The search can be further refined with industry-specific filters such as dossier type, country of origin, GMP approvals, and search criteria for Wholesaler, etc. helping to get in contact with the preferred manufacturer and supplier readily.